Randomised controlled feasibility study of the MyHealthAvatar-Diabetes smartphone app for reducing prolonged sitting time in Type 2 diabetes mellitus

Bailey, Daniel P. and Mugridge, Lucie H. and Dong, Feng and Zhang, Xu and Chater, Angel M. (2020) Randomised controlled feasibility study of the MyHealthAvatar-Diabetes smartphone app for reducing prolonged sitting time in Type 2 diabetes mellitus. International Journal of Environmental Research and Public Health, 17 (12). 4414. ISSN 1660-4601

[img]
Preview
Text (Bailey-etal-IJERPH-2020-Randomised-controlled-feasibility-study-of-the-MyHealthAvatar-Diabetes-smartphone-app)
Bailey_etal_IJERPH_2020_Randomised_controlled_feasibility_study_of_the_MyHealthAvatar_Diabetes_smartphone_app.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (753kB)| Preview

    Abstract

    This study evaluated the feasibility and acceptability of a self-regulation smartphone app for reducing prolonged sitting in people with Type 2 diabetes mellitus (T2DM). This was a two-arm randomised controlled feasibility trial. The intervention group used the MyHealthAvatar-Diabetes smartphone app for 8 weeks. The app uses a number of behaviour change techniques aimed at reducing and breaking up sitting time. Eligibility, recruitment, retention and completion rates for the outcomes (sitting, standing, stepping and health-related measures) assessed trial feasibility. Interviews with participants explored intervention acceptability. Participants with T2DM were randomised to the control (n=10) and intervention groups (n=10). Recruitment and retention rates were 71% and 90%, respectively. The remaining participants provided 100% of data for study measures. The MyHealthAvatar-Diabetes app was viewed as acceptable for reducing and breaking up sitting time. There were preliminary improvements in the number of breaks in sitting per day, body fat %, glucose tolerance, attitude, intention, planning, wellbeing, positive affect and negative affect in favour of the intervention group. In conclusion, the findings indicate that it would be feasible to deliver and evaluate the efficacy of the MyHealthAvatar-Diabetes app for breaking up sitting time and improving health outcomes in a full trial.